Director, Global Value & Access Strategy (Cell-Therapy Autoimmune)

We’re here for one reason and one reason only — to cure cancer. Every moment is dedicated to developing treatments and every action moves us one step closer to our goal. We’ve made incredible scientific breakthroughs and our pioneering personalized CAR T-cell therapies have changed the paradigm. But we’re not finished yet. Join Kite, as we make even bigger advances in cancer therapies, and help shape where our business and medical science goes next. We believe every employee deserves a great leader. People Leaders are the cornerstone to the employee experience at Gilead and Kite. As a people leader now or in the future, you are the key driver in evolving our culture and creating an environment where every employee feels included, developed and empowered to fulfil their aspirations. Join Kite and help create more tomorrows. Job Description We are seeking a Director, Global Value & Access Strategy (GVAS), Cell-therapy Autoimmune. This role reports to the Senior Director, GVA Lead, Lymphoma, Autoimmune and Solid Tumors/Pipeline. This role will be office-based/hybrid (3 days onsite) in El Segundo or Thousand Oaks or Foster City, CA. In this position, you will be a critical Global Value & Access partner for Kite’s growing autoimmune cell therapy portfolio. You will lead the development and execution of global market access strategies to support early and late-stage development programs, while preparing for future launches of transformative cell therapies across autoimmune diseases. You will work closely with Global Clinical Development, Medical Affairs, HE #J-18808-Ljbffr Kite Pharma, Inc.